Breast Cancer Research and Treatment

, Volume 144, Issue 3, pp 467–478

Breast cancer in Sub-Saharan Africa: opportunities for prevention

  • Louise A. Brinton
  • Jonine D. Figueroa
  • Baffour Awuah
  • Joel Yarney
  • Seth Wiafe
  • Shannon N. Wood
  • Daniel Ansong
  • Kofi Nyarko
  • Beatrice Wiafe-Addai
  • Joe Nat Clegg-Lamptey
Review

Abstract

Although breast cancer is a growing health problem in sub-Saharan Africa, reasons for its increased occurrence remain unclear. We reviewed the published literature to determine the magnitude of the increase in breast cancer, associated risk factors (including for breast cancer subtypes), and ways to reduce incidence and mortality. Some of the increased breast cancer occurrence likely reflects that women are living longer and adopting lifestyles that favor higher incidence rates. However, a greater proportion of breast cancers occur among premenopausal women as compared to elsewhere, which may reflect unique risk factors. Breast cancers diagnosed among African women reportedly include a disproportionate number of poor prognosis tumors, including hormone receptor negative, triple negative, and core basal phenotype tumors. However, it is unclear how lack of standardized methods for tissue collection, fixation, and classification contribute to these rates. Given appropriate classifications, it will be of interest to compare rates with other populations and to identify risk factors that relate to specific tumor subtypes. This includes not only risk factors that have been recognized in other populations but also some that may play unique roles among African women, such as genetic factors, microbiomata, xenoestrogens, hair relaxers, and skin lighteners. With limited opportunities for effective treatment, a focus is needed on identifying etiologic factors that may be amenable to intervention. It will also be essential to understand reasons why women delay seeking care after the onset of symptoms and for there to be educational campaigns about the importance of early detection.

Keywords

Breast cancer Sub-Saharan Africa Incidence Mortality Etiology Prevention 

References

  1. 1.
    Akarolo-Anthony SN, Ogundiran TO, Adebamowo CA (2010) Emerging breast cancer epidemic: evidence from Africa. Breast Cancer Res 12(Suppl 4):S8PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Sylla BS, Wild CP (2012) A million Africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? Int J Cancer 130:245–250PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Jemal A, Bray F, Forman D et al (2012) Cancer burden in Africa and opportunities for prevention. Cancer 118:4372–4384PubMedCrossRefGoogle Scholar
  4. 4.
    Parkin DM, Nambooze S, Wabwire-Mangen F, Wabinga HR (2010) Changing cancer incidence in Kampala, Uganda, 1991–2006. Int J Cancer 126:1187–1195PubMedGoogle Scholar
  5. 5.
    Soerjomataram I, Lortet-Tieulent J, Parkin DM et al (2012) Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 380:1840–1850PubMedCrossRefGoogle Scholar
  6. 6.
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917PubMedCrossRefGoogle Scholar
  7. 7.
    Ferlay J, Soerjomataram I, Ervik M et al (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, LyonGoogle Scholar
  8. 8.
    Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H (2008) Cancer in Indigenous Africans—burden, distribution, and trends. Lancet Oncol 9:683–692PubMedCrossRefGoogle Scholar
  9. 9.
    Forman D, Bray F, Brewster DH et al (2013) Cancer incidence in five continents (electronic version). IARC, LyonGoogle Scholar
  10. 10.
    Chokunonga E, Borok MZ, Chirenje ZM, Nyakabau AM, Parkin DM (2013) Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010. Int J Cancer 133:721–729PubMedCrossRefGoogle Scholar
  11. 11.
    Sighoko D, Kamate B, Traore C et al (2013) Breast cancer in pre-menopausal women in West Africa: analysis of temporal trends and evaluation of risk factors associated with reproductive life. Breast 22:828–835PubMedCrossRefGoogle Scholar
  12. 12.
    Brinton LA, Sherman ME, Carreon JD, Anderson WF (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100:1643–1648PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Parkin DM, Vizcaino AP, Skinner ME, Ndhlovu A (1994) Cancer patterns and risk factors in the African population of southwestern Zimbabwe, 1963-1977. Cancer Epidemiol Biomarkers Prev 3:537–547PubMedGoogle Scholar
  14. 14.
    Huo D, Adebamowo CA, Ogundiran TO et al (2008) Parity and breastfeeding are protective against breast cancer in Nigerian women. Br J Cancer 98:992–996PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Palmer JR, Wise LA, Horton NJ, Adams-Campbell LL, Rosenberg L (2003) Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst 95:478–483PubMedCrossRefGoogle Scholar
  16. 16.
    Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO (1994) Transient increase in the risk of breast cancer after giving birth. N Engl J Med 331:5–9PubMedCrossRefGoogle Scholar
  17. 17.
    Okobia M, Bunker C, Zmuda J et al (2006) Case-control study of risk factors for breast cancer in Nigerian women. Int J Cancer 119:2179–2185PubMedCrossRefGoogle Scholar
  18. 18.
    Jordan I, Hebestreit A, Swai B, Krawinkel MB (2010). Breast cancer risk among women with long-standing lactation and reproductive parameters at low risk level: a case-control study in Northern Tanzania. Breast Cancer ResTreat. doi 10.1007/s10549-010-1255-7
  19. 19.
    Adebamowo CA, Ogundiran TO, Adenipekun AA et al (2003) Obesity and height in urban Nigerian women with breast cancer. Ann Epidemiol 13:455–461PubMedCrossRefGoogle Scholar
  20. 20.
    Coogan PF, Rosenberg L, Shapiro S, Hoffman M (1999) Lactation and breast carcinoma risk in a South African population. Cancer 86:982–989PubMedCrossRefGoogle Scholar
  21. 21.
    Baquet CR, Commiskey P (2000) Socioeconomic factors and breast carcinoma in multicultural women. Cancer 88:1256–1264PubMedCrossRefGoogle Scholar
  22. 22.
    The World Bank (2013) African development indicators 2012/13 [electronic]. Washington, DCGoogle Scholar
  23. 23.
    Sitas F, Parkin DM, Chirenje M, Stein L, Abratt R, Wabinga\ H (2008) Cancer in Indigenous Africans—causes and control. Lancet Oncol 9:786–795PubMedCrossRefGoogle Scholar
  24. 24.
    Urban M, Banks E, Egger S et al (2012) Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study. PLoS Med 9:e1001182PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Ogundiran TO, Huo D, Adenipekun A et al (2010) Case-control study of body size and breast cancer risk in Nigerian women. Am J Epidemiol 172:682–690PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Ogundiran TO, Huo D, Adenipekun A et al (2012) Body fat distribution and breast cancer risk: findings from the Nigerian breast cancer study. Cancer Causes Control 23:565–574PubMedCrossRefGoogle Scholar
  27. 27.
    Okobia MN, Bunker CH, Zmuda JM et al (2006) Anthropometry and breast cancer risk in Nigerian women. Breast J 12:462–466PubMedCrossRefGoogle Scholar
  28. 28.
    Jordan I, Hebestreit A, Swai B, Krawinkel MB (2013) Dietary patterns and breast cancer risk among women in northern Tanzania: a case-control study. Eur J Nutr 52:905–915PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Okobia MN, Bunker CH, Garte SJ et al (2008) Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study. BMC Cancer 8:338PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Okobia MN, Bunker CH, Garte SJ et al (2009) Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control study. Infect Agent Cancer 4(Suppl 1):S12PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Mai V, Draganov PV (2009) Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health. World J Gastroenterol 15:81–85PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Kortenkamp A (2006) Breast cancer, oestrogens and environmental pollutants: a re-evaluation from a mixture perspective. Int J Androl 29:193–198PubMedCrossRefGoogle Scholar
  33. 33.
    Dey S, Soliman AS, Merajver SD (2009) Xenoestrogens may be the cause of high and increasing rates of hormone receptor positive breast cancer in the world. Med Hypotheses 72:652–656PubMedCrossRefGoogle Scholar
  34. 34.
    Etemesi BA (2007) Impact of hair relaxers in women in Nakuru, Kenya. Int J Dermatol 46(Suppl 1):23–25PubMedCrossRefGoogle Scholar
  35. 35.
    Rosenberg L, Boggs DA, Adams-Campbell LL, Palmer JR (2007) Hair relaxers not associated with breast cancer risk: evidence from the black women’s health study. Cancer Epidemiol Biomarkers Prev 16:1035–1037PubMedCrossRefGoogle Scholar
  36. 36.
    Wise LA, Palmer JR, Reich D, Cozier YC, Rosenberg L (2012) Hair relaxer use and risk of uterine leiomyomata in african-american women. Am J Epidemiol 175:432–440PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Nnoruka E, Okoye O (2006) Topical steroid abuse: its use as a depigmenting agent. J Natl Med Assoc 98:934–939PubMedCentralPubMedGoogle Scholar
  38. 38.
    Olumide YM, Akinkugbe AO, Altraide D et al (2008) Complications of chronic use of skin lightening cosmetics. Int J Dermatol 47:344–353PubMedCrossRefGoogle Scholar
  39. 39.
    Rosenberg L, Kelly JP, Shapiro S, Hoffman M, Cooper D (2002) Risk factors for breast cancer in South African women. S Afr Med J 92:447–448PubMedGoogle Scholar
  40. 40.
    Garcia-Closas M, Couch FJ, Lindstrom S et al (2013) Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 45:392PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Michailidou K, Hall P, Gonzalez-Neira A et al (2013) Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 45:353PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Chen F, Chen GK, Stram DO et al (2013) A genome-wide association study of breast cancer in women of African ancestry. Hum Genet 132:39–48PubMedCentralPubMedCrossRefGoogle Scholar
  43. 43.
    Garcia-Closas M, Brinton LA, Lissowska J et al (2006) Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer 95:123–129PubMedCentralPubMedCrossRefGoogle Scholar
  44. 44.
    Yang XR, Chang-Claude J, Goode EL et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103:250–263PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE (2008) Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 110:183–188PubMedCrossRefGoogle Scholar
  46. 46.
    Agboola AJ, Musa AA, Wanangwa N et al (2012) Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women. Breast Cancer Res Treat 135:555–569PubMedCrossRefGoogle Scholar
  47. 47.
    Awadelkarim KD, Arizzi C, Elamin EO et al (2008) Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa. Histopathology 52:445–456PubMedCrossRefGoogle Scholar
  48. 48.
    Bird PA, Hill AG, Houssami N (2008) Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease? Ann Surg Oncol 15:1983–1988PubMedCrossRefGoogle Scholar
  49. 49.
    Burson AM, Soliman AS, Ngoma TA et al (2010) Clinical and epidemiologic profile of breast cancer in Tanzania. Breast Dis 31:33–41PubMedGoogle Scholar
  50. 50.
    Gukas ID, Jennings BA, Mandong BM et al (2005) Clinicopathological features and molecular markers of breast cancer in Jos, Nigeria. West Afr J Med 24:209–213PubMedGoogle Scholar
  51. 51.
    Huo D, Ikpatt F, Khramtsov A et al (2009) Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 27:4515–4521PubMedCentralPubMedCrossRefGoogle Scholar
  52. 52.
    Ikpatt OF, Ndoma-Egba R (2003) Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients. Cent Afr J Med 49:122–126PubMedGoogle Scholar
  53. 53.
    Ly M, Antoine M, Dembele AK et al (2012) High incidence of triple-negative tumors in sub-saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital. Oncology 83:257–263PubMedCrossRefGoogle Scholar
  54. 54.
    Nyagol J, Nyong’o A, Byakika B et al (2006) Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer. Anal Quant Cytol Histol 28:97–103PubMedGoogle Scholar
  55. 55.
    Ohene-Yeboah M, Adjei E (2012) Breast cancer in Kumasi, Ghana. Ghana Med J 46:8–13PubMedCentralPubMedGoogle Scholar
  56. 56.
    Stark A, Kleer CG, Martin I et al (2010) African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study. Cancer 116:4926–4932PubMedCentralPubMedCrossRefGoogle Scholar
  57. 57.
    Yarney J, Vanderpuye V, Clegg Lamptey JN (2008) Hormone receptor and HER-2 expression in breast cancers among Sub-Saharan African women. Breast J 14:510–511PubMedCrossRefGoogle Scholar
  58. 58.
    McCormack VA, Joffe M, van den Berg E et al (2013) Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series. Breast Cancer Res 15:R84PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Clegg-Lamptey JN, Dakubo JC, Attobra YN (2009) Psychosocial aspects of breast cancer treatment in Accra, Ghana. East Afr Med J 86:348–353PubMedGoogle Scholar
  60. 60.
    Ibrahim NA, Oludara MA (2012) Socio-demographic factors and reasons associated with delay in breast cancer presentation: a study in Nigerian women. Breast 21:416–418PubMedCrossRefGoogle Scholar
  61. 61.
    Yarney J, Donkor A, Opoku SY et al (2013) Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross-sectional study. BMC Complement Altern Med 13:16PubMedCentralPubMedCrossRefGoogle Scholar
  62. 62.
    Adesunkanmi AR, Lawal OO, Adelusola KA, Durosimi MA (2006) The severity, outcome and challenges of breast cancer in Nigeria. Breast 15:399–409PubMedCrossRefGoogle Scholar
  63. 63.
    De Ver DT, Bogale S, Hobden C et al (2011) A mixed-method assessment of beliefs and practice around breast cancer in Ethiopia: implications for public health programming and cancer control. Glob Public Health 6:719–731CrossRefGoogle Scholar
  64. 64.
    Clegg-Lamptey J, Dakubo J, Attobra YN (2009) Why do breast cancer patients report late or abscond during treatment in Ghana? A pilot study. Ghana Med J 43:127–131PubMedCentralPubMedGoogle Scholar
  65. 65.
    Odigie VI, Tanaka R, Yusufu LM et al (2010) Psychosocial effects of mastectomy on married African women in Northwestern Nigeria. Psychooncology 19:893–897PubMedCrossRefGoogle Scholar
  66. 66.
    Okobia MN, Bunker CH, Okonofua FE, Osime U (2006) Knowledge, attitude and practice of Nigerian women towards breast cancer: a cross-sectional study. World J Surg Oncol 4:11PubMedCentralPubMedCrossRefGoogle Scholar
  67. 67.
    Machlin A, Wakefield M, Spittal M, Hill D (2009) Cancer related beliefs and behaviours in eight geographic regions. UICC Special ReportGoogle Scholar
  68. 68.
    Maree J, Wright S, Lu X (2013) Breast cancer risks and screening practices among women living in a resource poor community in Tshwane, South Africa. Breast J 19:453–454PubMedCrossRefGoogle Scholar
  69. 69.
    Pillay AL (2002) Rural and urban South African women’s awareness of cancers of the breast and cervix. Ethn Health 7:103–114PubMedCrossRefGoogle Scholar
  70. 70.
    Suh MA, Atashili J, Fuh EA, Eta VA (2012) Breast self-examination and breast cancer awareness in women in developing countries: a survey of women in Buea, Cameroon. BMC Res Notes 5:627PubMedCentralPubMedCrossRefGoogle Scholar
  71. 71.
    Ezeome ER (2010) Delays in presentation and treatment of breast cancer in Enugu, Nigeria. Niger J Clin Pract 13:311–316PubMedGoogle Scholar
  72. 72.
    O’Brien KS, Soliman AS, Annan K, Lartey RN, Awuah B, Merajver SD (2012) Traditional herbalists and cancer management in Kumasi, Ghana. J Cancer Educ 27:573–579PubMedCrossRefGoogle Scholar
  73. 73.
    Opoku SY, Benwell M, Yarney J (2012) Knowledge, attitudes, beliefs, behaviour and breast cancer screening practices in Ghana, West Africa. Pan Afr Med J 11:28PubMedCentralPubMedGoogle Scholar
  74. 74.
    Kemfang Ngowa JD, Yomi J, Kasia JM, Mawamba Y, Ekortarh AC, Vlastos G (2011) Breast cancer profile in a group of patients followed up at the radiation therapy unit of the Yaounde General Hospital, Cameroon. Obstet Gynecol Int 2011:143506Google Scholar
  75. 75.
    Clegg-Lamptey J, Hodasi W (2007) A study of breast cancer in Korle Bu teaching hospital: assessing the impact of health education. Ghana Med J 41:72–77PubMedCentralPubMedGoogle Scholar
  76. 76.
    Dickens C, Joffe M, Jacobson J et al (in press) Stage at breast cancer diagnosis and distance from diagnostic hospital in a peri-urban setting: a South African public hospital case series of over 1000 women. Int J CancerGoogle Scholar
  77. 77.
    Adisa AO, Gukas ID, Lawal OO, Adesunkanmi AR (2010) Breast cancer in Nigeria: is non-adherence to chemotherapy schedules a major factor in the reported poor treatment outcome? Breast J 16:206–207PubMedCrossRefGoogle Scholar
  78. 78.
    Galukande M, Kiguli-Malwadde E (2010) Rethinking breast cancer screening strategies in resource-limited settings. Afr Health Sci 10:89–92PubMedCentralPubMedGoogle Scholar
  79. 79.
    Zelle SG, Nyarko KM, Bosu WK et al (2012) Costs, effects and cost-effectiveness of breast cancer control in Ghana. Trop Med Int Health 17:1031–1043PubMedCrossRefGoogle Scholar
  80. 80.
    Barton MB, Frommer M, Shafiq J (2006) Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol 7:584–595PubMedCrossRefGoogle Scholar
  81. 81.
    Abdel-Wahab M, Bourque JM, Pynda Y et al (2013) Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis. Lancet Oncol 14:e168–e175PubMedCrossRefGoogle Scholar
  82. 82.
    Kingham TP, Alatise OI, Vanderpuye V et al (2013) Treatment of cancer in sub-Saharan Africa. Lancet Oncol 14:e158–e167PubMedCrossRefGoogle Scholar
  83. 83.
    Olugbenga-Bello A, Oladele EA, Bello TO, Ojo JO, Oguntola AS (2011) Awareness and breast cancer risk factors: perception and screening practices among females in a tertiary institution in Southwest Nigeria. Niger Postgrad Med J 18:8–15PubMedGoogle Scholar
  84. 84.
    Stefan DC, Elzawawy AM, Khaled HM et al (2013) Developing cancer control plans in Africa: examples from five countries. Lancet Oncol 14:e189–e195PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York (outside the USA) 2014

Authors and Affiliations

  • Louise A. Brinton
    • 1
  • Jonine D. Figueroa
    • 1
  • Baffour Awuah
    • 2
  • Joel Yarney
    • 3
  • Seth Wiafe
    • 4
  • Shannon N. Wood
    • 1
  • Daniel Ansong
    • 2
  • Kofi Nyarko
    • 3
  • Beatrice Wiafe-Addai
    • 5
  • Joe Nat Clegg-Lamptey
    • 3
  1. 1.National Cancer InstituteNational Institutes of HealthBethesdaUSA
  2. 2.Komfo Anoyke Teaching HospitalKumasiGhana
  3. 3.Korle Bu Teaching HospitalAccraGhana
  4. 4.Loma Linda UniversityLoma LindaUSA
  5. 5.Peace and Love HospitalKumasiGhana

Personalised recommendations